Area of research
Pathology and Forensic Medicine · Cardiology and Cardiovascular Medicine
Research interest
Research interests include Cardiac Ischemia and Reperfusion, Nitric Oxide and Endothelin Effects, Cardiac Fibrosis and Remodeling, and Cardiac Arrest and Resuscitation.
Guidance on the planning and reporting of experimental design and analysis
Novel drugs approved by the EMA, the FDA and the MHRA in 2024: A year in review
Natural product pharmacology: the British Journal of Pharmacology perspective
Novel drugs approved by the EMA, the FDA, and the MHRA in 2023: A year in review
Heart failure pharmacotherapy and cancer: pathways and pre-clinical/clinical evidence
Update on antithrombotic therapy and body mass: a clinical consensus statement of the European Society of Cardiology Working Group on Cardiovascular Pharmacotherapy and the European Society of Cardiology Working Group on Thrombosis
The IMproving Preclinical Assessment of Cardioprotective Therapies (IMPACT): multicenter pig study on the effect of ischemic preconditioning
Health position paper and redox perspectives on reactive oxygen species as signals and targets of cardioprotection
New pharmacological agents and novel cardiovascular pharmacotherapy strategies in 2022
The Semmelweis Study: a longitudinal occupational cohort study within the framework of the Semmelweis Caring University Model Program for supporting healthy aging
Considering and reporting sex as an experimental variable II: An update on progress in the <i>British Journal of Pharmacology</i>
BJP recommendations for publishing research on tobacco smoke and environmental tobacco smoke exposure
Long COVID and the cardiovascular system—elucidating causes and cellular mechanisms in order to develop targeted diagnostic and therapeutic strategies: a joint Scientific Statement of the ESC Working Groups on Cellular Biology of the Heart and Myocardial and Pericardial Diseases
Animal models and animal-free innovations for cardiovascular research: current status and routes to be explored. Consensus document of the ESC Working Group on Myocardial Function and the ESC Working Group on Cellular Biology of the Heart
Utrecht University Repository (Utrecht University) 2022cited by 66position: middle
IMproving Preclinical Assessment of Cardioprotective Therapies (IMPACT) criteria: guidelines of the EU-CARDIOPROTECTION COST Action
Prognostically relevant periprocedural myocardial injury and infarction associated with percutaneous coronary interventions: a Consensus Document of the ESC Working Group on Cellular Biology of the Heart and European Association of Percutaneous Cardiovascular Interventions (EAPCI)
Influence of cardiometabolic comorbidities on myocardial function, infarction, and cardioprotection: Role of cardiac redox signaling
COVID-19-related cardiac complications from clinical evidences to basic mechanisms: opinion paper of the ESC Working Group on Cellular Biology of the Heart
Circadian rhythms in ischaemic heart disease: key aspects for preclinical and translational research: position paper of the ESC working group on cellular biology of the heart
The Cancer Patient and Cardiology
Cardiac dysfunction in cancer patients: beyond direct cardiomyocyte damage of anticancer drugs: novel cardio-oncology insights from the joint 2019 meeting of the ESC Working Groups of Myocardial Function and Cellular Biology of the Heart
The role of mitochondrial reactive oxygen species, NO and H<sub>2</sub>S in ischaemia/reperfusion injury and cardioprotection
Improving translational research in sex-specific effects of comorbidities and risk factors in ischaemic heart disease and cardioprotection: position paper and recommendations of the ESC Working Group on Cellular Biology of the Heart
Cardiomyocyte ageing and cardioprotection: consensus document from the ESC working groups cell biology of the heart and myocardial function
A global network for network medicine
Multitarget Strategies to Reduce Myocardial Ischemia/Reperfusion Injury
ESC Working Group on Cellular Biology of the Heart: position paper for Cardiovascular Research: tissue engineering strategies combined with cell therapies for cardiac repair in ischaemic heart disease and heart failure
Cardiac innervation in acute myocardial ischaemia/reperfusion injury and cardioprotection
Catalyzing Transcriptomics Research in Cardiovascular Disease: The CardioRNA COST Action CA17129
Practical guidelines for rigor and reproducibility in preclinical and clinical studies on cardioprotection